Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -87.26% | 60.48% | 14,256.25% | 2,175.41% | 138.59% |
| Total Receivables | 152.78% | 157.80% | 206.83% | 217.68% | 267.42% |
| Inventory | 117.71% | -26.21% | 1,344.16% | 710.53% | 509.21% |
| Prepaid Expenses | -64.52% | 102.58% | -42.42% | -22.31% | -46.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -49.93% | 66.76% | 853.17% | 266.20% | 83.27% |
|
|
|||||
| Total Current Assets | -49.93% | 66.76% | 853.17% | 266.20% | 83.27% |
| Net Property, Plant & Equipment | 17.62% | 12.39% | 7.76% | 6.25% | 1.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.19% | 0.00% | -1.92% | -0.97% | -5.83% |
| Total Assets | -1.17% | 19.84% | 54.76% | 25.84% | 15.93% |
|
|
|||||
| Total Accounts Payable | -15.87% | -9.29% | 21.12% | 26.70% | 58.29% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 203.01% | -15.03% | 83.98% | 129.02% | -- |
| Total Other Current Liabilities | 203.01% | -15.03% | 83.98% | 129.02% | -- |
| Total Current Liabilities | 26.30% | -13.20% | 60.41% | 92.05% | 93.63% |
|
|
|||||
| Total Current Liabilities | 26.30% | -13.20% | 60.41% | 92.05% | 93.63% |
| Long-Term Debt | -- | 0.00% | -1.69% | -0.68% | -6.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -1.92% | -0.97% | -5.83% |
| Total Liabilities | 22.83% | -13.52% | 57.99% | 87.41% | 88.18% |
|
|
|||||
| Common Stock & APIC | 29.24% | 38.88% | 29.76% | 15.40% | 9.31% |
| Retained Earnings | -36.18% | -32.98% | -27.81% | -20.74% | -15.88% |
| Treasury Stock & Other | -54.55% | 0.67% | -34.09% | 23.47% | 120.00% |
| Total Common Equity | -41.07% | 179.11% | 50.01% | -27.36% | -29.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.07% | 179.11% | 50.01% | -27.36% | -29.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.07% | 179.11% | 50.01% | -27.36% | -29.22% |
|
|
|||||